Sanofi-Aventis' Adacel Launch Plans Await CDC Recommendations
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA clears the tetanus, diphtheria, pertussis booster vaccine for individuals ages 11-64. Phase IV commitments include a concomitant use study with Sanofi's meningococcal vaccine Menactra.